Abcam plc Introduces Alexa Fluor® 680/790 Secondary Antibodies For Fluorescent Western Blotting

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Cambridge, UK, March 03 2014: Abcam plc, a global leader in the supply of innovative protein research tools, announced today it has added Alexa Fluor® 680/790 secondary antibodies for fluorescent western blotting to its existing Alexa Fluor conjugated antibody range.

Produced and extensively validated in Abcam laboratories, the F:P ratios of Alexa Fluor 680/790 have been optimised to ensure high quality and performance. The expanding range offers a broad portfolio of labelled secondary antibodies with guaranteed bright staining and low background to meet the different needs of researchers undertaking multi-colour analysis.

Brian Carpenter, Product Manager, Secondary Antibodies, Abcam, commented: “The popularity of fluorescent western blotting is growing and presents many advantages over the traditional method. With no need for film and chemiluminesence, fluorescent western blotting is more convenient and enables greater signal stability and the ability to facilitate simultaneous multi-colour analysis on one blot. High performing antibodies are crucial for fluorescent western blotting and we’re pleased that our new Alexa Fluor680/790 secondary antibodies can support this trend.”

Abcam Alexa Fluor secondaries are ideal for scientists undertaking multi-colour staining from all research backgrounds. The addition of these products complements Abcam’s innovative RabMAb® primary products and market leading primary antibody range.

Abcam Alexa Fluor secondaries are supported by expert scientific support, information-rich datasheets, and are available globally with fast delivery either directly through the Abcam website or via one of Abcam’s authorised distributors.

To find out more, please visit www.abcam.com/Fluorescent-WB

Alexa Fluor® is a registered trademark of Life Technologies. Alexa Fluor® dye conjugates contain(s) technology licensed to Abcam by Life Technologies.

For a high resolution image, please contact Zyme Communications.

Contacts:
Abcam
Francesca Axe
T: +44 (0) 1223 696000

Media enquiries
Katie Odgaard
Zyme Communications
E: katie.odgaard@zymecommunications.com
T: +44 (0) 7787 502 947

About Abcam
Abcam plc is a global leader in the supply of innovative protein research tools, with a wide range of products and expert technical support, enabling scientists to analyse living cells at the molecular level and improving the understanding of health and disease.

Abcam is committed to providing scientists with an extensive choice of reagents and tools, with the most comprehensive, honest and up-to-date datasheets and customer reviews, fast delivery and helpful customer service & technical support. The Company’s catalogue evolves with scientific research trends and is growing each year to provide customers with products to meet their research needs. The range now includes primary and secondary antibodies, proteins, peptides, lysates, biochemicals, immunoassays and other kits. Abcam also supports its customers by hosting a range of global scientific events, forums and webinars, providing opportunities for scientists to get together and present their work.

Headquartered in Cambridge, UK, Abcam has nine global subsidiary offices enabling local services, multi-language support and next-day delivery to over 100 countries. The Company was founded in 1998, and now employs over 700 FTEs. Abcam was admitted to AIM in 2005 (AIM: ABC).

To find out more, please visit www.abcam.com

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC